Novel Glypican-3-Binding Peptide for in Vivo Hepatocellular Carcinoma Fluorescent Imaging

Bioconjugate Chemistry

Volumn 27, Issue 3, 2016, Pages 831-839

  Zhu, Dongling ^a   Qin, Yushuang ^a   Wang, Jingjing ^b   Zhang, Liwen ^b   Zou, Sijuan ^a   Zhu, Xiaohua ^a   Zhu, Lei ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; CELL CULTURE; CELL MEMBRANES; DIAGNOSIS; DISEASES; FLUORESCENCE IMAGING; INFRARED DEVICES; LIGANDS; PEPTIDES;

ANGIOGENESIS; BINDING PEPTIDE; CELL SURFACES; FLUORESCENT IMAGING; GLYCOSYL; GLYPICAN-3; HEPATOCELLULAR CARCINOMA; IN-VIVO; LIVER LESIONS; TUMOR DEVELOPMENT;

TUMORS;

FLUORESCENT DYE; GLYPICAN 3; PEPTIDE; GLYPICAN; GPC3 PROTEIN, HUMAN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CANCER SCREENING; CONTROLLED STUDY; FEMALE; FLUORESCENT IMAGING; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IMAGING; IN VIVO STUDY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PHAGE DISPLAY; PROSTATE CANCER CELL LINE; XENOGRAFT; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; HEP-G2 CELL LINE; LIVER TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY;

AMINO ACID SEQUENCE; ANIMALS; CARCINOMA, HEPATOCELLULAR; GLYPICANS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MICE; MICE, NUDE;

EID: 84962330830     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/acs.bioconjchem.6b00030     Document Type: Article

References (39)

1. Forner, A., Llovet, J. M., and Bruix, J. (2012) Hepatocellular carcinoma Lancet 379, 1245-1255 10.1016/S0140-6736(11)61347-0
2. Lencioni, R. (2010) Loco-regional treatment of hepatocellular carcinoma Hepatology 52, 762-773 10.1002/hep.23725
3. Kim, H. and Park, Y. N. (2014) Role of biopsy sampling for diagnosis of early and progressed hepatocellular carcinoma Bes.t Pract. Res., Clin. Gastroenterol. 28, 813-829 10.1016/j.bpg.2014.08.012
4. Tafreshi, N. K., Enkemann, S. A., Bui, M. M., Lloyd, M. C., Abrahams, D., Huynh, A. S., Kim, J., Grobmyer, S. R., Carter, W. B., Vagner, J., Gillies, R. J., and Morse, D. L. (2011) A mammaglobin-a targeting agent for noninvasive detection of breast cancer metastasis in lymph nodes Cancer Res. 71, 1050-1059 10.1158/0008-5472.CAN-10-3091
5. Attwa, M. H. and El-Etreby, S. A. (2015) Guide for diagnosis and treatment of hepatocellular carcinoma World J. Hepatol. 7, 1632-1651 10.4254/wjh.v7.i12.1632
6. Filmus, J., Capurro, M., and Rast, J. (2008) Glypicans Genome Biol. 9, 224 10.1186/gb-2008-9-5-224
7. Capurro, M., Wanless, I. R., Sherman, M., Deboer, G., Shi, W., Miyoshi, E., and Filmus, J. (2003) Glypican-3: A novel serum and histochemical marker for hepatocellular carcinoma Gastroenterology 125, 89-97 10.1016/S0016-5085(03)00689-9
8. Hsu, H. C., Cheng, W., and Lai, P. L. (1997) Cloning and expression of a developmentally regulated transcript mxr7 in hepatocellular carcinoma: Biological significance and temporospatial distribution Cancer Res. 57, 5179-5184
9. Liu, X., Wang, S. K., Zhang, K., Zhang, H., Pan, Q., Liu, Z., Pan, H., Xue, L., Yen, Y., and Chu, P. G. (2015) Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers Carcinogenesis 36, 232-242 10.1093/carcin/bgu245
10. Midorikawa, Y., Ishikawa, S., Iwanari, H., Imamura, T., Sakamoto, H., Miyazono, K., Kodama, T., Makuuchi, M., and Aburatani, H. (2003) Glypican-3, overexpressed in hepatocellular carcinoma, modulates fgf2 and bmp-7 signaling Int. J. Cancer 103, 455-465 10.1002/ijc.10856
11. Gao, W., Kim, H., Feng, M., Phung, Y., Xavier, C. P., Rubin, J. S., and Ho, M. (2014) Inactivation of wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy Hepatology 60, 576-587 10.1002/hep.26996
12. Miao, H. L., Pan, Z. J., Lei, C. J., Wen, J. Y., Li, M. Y., Liu, Z. K., Qiu, Z. D., Lin, M. Z., Chen, N. P., and Chen, M. (2013) Knockdown of gpc3 inhibits the proliferation of huh7 hepatocellular carcinoma cells through down-regulation of yap J. Cell. Biochem. 114, 625-631 10.1002/jcb.24404
13. Capurro, M., Martin, T., Shi, W., and Filmus, J. (2014) Glypican-3 binds to frizzled and plays a direct role in the stimulation of canonical wnt signaling J. Cell Sci. 127, 1565-1575 10.1242/jcs.140871
14. Zittermann, S. I., Capurro, M. I., Shi, W., and Filmus, J. (2010) Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo Int. J. Cancer 126, 1291-1301 10.1002/ijc.24941
15. Feng, M., Gao, W., Wang, R., Chen, W., Man, Y. G., Figg, W. D., Wang, X. W., Dimitrov, D. S., and Ho, M. (2013) Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma Proc. Natl. Acad. Sci. U. S. A. 110, E1083-1091 10.1073/pnas.1217868110
16. Yang, X., Liu, H., Sun, C. K., Natarajan, A., Hu, X., Wang, X., Allegretta, M., Guttmann, R. D., Gambhir, S. S., Chua, M. S., Cheng, Z., and So, S. K. (2014) Imaging of hepatocellular carcinoma patient-derived xenografts using (8)(9)zr-labeled anti-glypican-3 monoclonal antibody Biomaterials 35, 6964-6971 10.1016/j.biomaterials.2014.04.089
17. Sham, J. G., Kievit, F. M., Grierson, J. R., Miyaoka, R. S., Yeh, M. M., Zhang, M., Yeung, R. S., Minoshima, S., and Park, J. O. (2014) Glypican-3-targeted 89zr pet imaging of hepatocellular carcinoma J. Nucl. Med. 55, 799-804 10.2967/jnumed.113.132118
18. Sham, J. G., Kievit, F. M., Grierson, J. R., Chiarelli, P. A., Miyaoka, R. S., Zhang, M., Yeung, R. S., Minoshima, S., and Park, J. O. (2014) Glypican-3-targeting f(ab′)2 for 89zr pet of hepatocellular carcinoma J. Nucl. Med. 55, 2032-2037 10.2967/jnumed.114.145102
19. Mendler, C. T., Gehring, T., Wester, H. J., Schwaiger, M., and Skerra, A. (2015) 8)(9)zr-labeled versus (1)(2)(4)i-labeled alphaher2 fab with optimized plasma half-life for high-contrast tumor imaging in vivo J. Nucl. Med. 56, 1112-1118 10.2967/jnumed.114.149690
20. Zhu, L., Niu, G., Fang, X., and Chen, X. (2010) Preclinical molecular imaging of tumor angiogenesis Q. J. Nucl. Med. Mol. Imaging 54, 291-308
21. Ye, Y., Zhu, L., Ma, Y., Niu, G., and Chen, X. (2011) Synthesis and evaluation of new irgd peptide analogs for tumor optical imaging Bioorg. Med. Chem. Lett. 21, 1146-1150 10.1016/j.bmcl.2010.12.112
22. Zhu, L., Guo, N., Li, Q., Ma, Y., Jacboson, O., Lee, S., Choi, H. S., Mansfield, J. R., Niu, G., and Chen, X. (2012) Dynamic pet and optical imaging and compartment modeling using a dual-labeled cyclic rgd peptide probe Theranostics 2, 746-756 10.7150/thno.4762
23. Zhu, L., Zhang, F., Ma, Y., Liu, G., Kim, K., Fang, X., Lee, S., and Chen, X. (2011) In vivo optical imaging of membrane-type matrix metalloproteinase (mt-mmp) activity Mol. Pharmaceutics 8, 2331-2338 10.1021/mp2002297
24. Zhu, L., Xie, J., Swierczewska, M., Zhang, F., Quan, Q., Ma, Y., Fang, X., Kim, K., Lee, S., and Chen, X. (2011) Real-time video imaging of protease expression in vivo Theranostics 1, 18-27 10.7150/thno/v01p0018
25. Yang, K., Zhu, L., Nie, L. M., Sun, X. L., Cheng, L., Wu, C. X., Niu, G., Chen, X. Y., and Liu, Z. (2014) Visualization of protease activity in vivo using an activatable photo-acoustic imaging probe based on cus nanoparticles Theranostics 4, 134-141 10.7150/thno.7217
26. Gao, S., Zhang, L., Wang, G., Yang, K., Chen, M., Tian, R., Ma, Q., and Zhu, L. (2016) Hybrid graphene/au activatable theranostic agent for multimodalities imaging guided enhanced photothermal therapy Biomaterials 79, 36-45 10.1016/j.biomaterials.2015.11.041
27. Hofmeister, L. H., Lee, S. H., Norlander, A. E., Montaniel, K. R., Chen, W., Harrison, D. G., and Sung, H. J. (2015) Phage-display-guided nanocarrier targeting to atheroprone vasculature ACS Nano 9, 4435-4446 10.1021/acsnano.5b01048
28. Li, J., Feng, L., Fan, L., Zha, Y., Guo, L., Zhang, Q., Chen, J., Pang, Z., Wang, Y., Jiang, X., Yang, V. C., and Wen, L. (2011) Targeting the brain with peg-plga nanoparticles modified with phage-displayed peptides Biomaterials 32, 4943-4950 10.1016/j.biomaterials.2011.03.031
29. Yang, M., Liu, C., Niu, M., Hu, Y., Guo, M., Zhang, J., Luo, Y., Yuan, W., Yang, M., Yun, M., Guo, L., Yan, J., Liu, D., Liu, J., and Jiang, Y. (2014) Phage-display library biopanning and bioinformatic analysis yielded a high-affinity peptide to inflamed vascular endothelium both in vitro and in vivo J. Controlled Release 174, 72-80 10.1016/j.jconrel.2013.11.009
30. Zhu, L., Wang, H., Wang, L., Wang, Y., Jiang, K., Li, C., Ma, Q., Gao, S., Wang, L., Li, W., Cai, M., Wang, H., Niu, G., Lee, S., Yang, W., Fang, X., and Chen, X. (2011) High-affinity peptide against mt1-mmp for in vivo tumor imaging J. Controlled Release 150, 248-255 10.1016/j.jconrel.2011.01.032
31. Li, Y., Chen, Z., Li, F., Wang, J., and Zhang, Z. (2012) Preparation and in vitro studies of mri-specific superparamagnetic iron oxide antigpc3 probe for hepatocellular carcinoma Int. J. Nanomed. 7, 4593-4611 10.2147/IJN.S32196
32. Chen, X., Park, R., Tohme, M., Shahinian, A. H., Bading, J. R., and Conti, P. S. (2004) Micropet and autoradiographic imaging of breast cancer alpha v-integrin expression using 18f- A nd 64cu-labeled rgd peptide Bioconjugate Chem. 15, 41-49 10.1021/bc0300403
33. Chen, H., Zhang, X., Dai, S., Ma, Y., Cui, S., Achilefus, S., and Gu, Y. (2013) Multifunctional gold nanostar conjugates for tumor imaging and combined photothermal and chemo-therapy Theranostics 3, 633-649 10.7150/thno.6630
34. Chen, K., Xie, J., Xu, H., Behera, D., Michalski, M. H., Biswal, S., Wang, A., and Chen, X. (2009) Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting Biomaterials 30, 6912-6919 10.1016/j.biomaterials.2009.08.045
35. Sun, X., Huang, X., Yan, X., Wang, Y., Guo, J., Jacobson, O., Liu, D., Szajek, L. P., Zhu, W., Niu, G., Kiesewetter, D. O., Sun, S., and Chen, X. (2014) Chelator-free (64)Cu-integrated gold nanomaterials for positron emission tomography imaging guided photothermal cancer therapy ACS Nano 8, 8438-8446 10.1021/nn502950t
36. Lee, Y., Ahn, B., Lee, Y., Lee, S., Cho, J., and Lee, J. (2011) Targeting of Hepatocellular Carcinoma with Glypican-3-targeting Peptide Ligand J. Pept. Sci. 17, 763-769
37. Frangioni, J. V. (2003) In vivo near-infrared fluorescence imaging Curr. Opin. Chem. Biol. 7, 626-634 10.1016/j.cbpa.2003.08.007
38. Liu, Z., Liu, S., Niu, G., Wang, F., Liu, S., and Chen, X. (2010) Optical imaging of integrin alphavbeta3 expression with near-infrared fluorescent RGD dimer with tetra(ethylene glycol) linkers Mol. Imaging 9, 21-29
39. Gao, D., Gao, L., Zhang, C., Liu, H., Jia, B., Zhu, Z., Wang, F., and Liu, Z. (2015) A near-infrared phthalocyanine dye-labeled agent for integrin alphavbeta6-targeted theranostics of pancreatic cancer Biomaterials 53, 229-238 10.1016/j.biomaterials.2015.02.093